Literature DB >> 10352740

Cystic dystrophy in heterotopic pancreas of the duodenal wall: medical and surgical treatment.

R Rubay1, D Bonnet, P Gohy, A Laka, D Deltour.   

Abstract

A patient with cystic dystrophy in heterotopic pancreatic tissue, localized in the second duodenum, is described. Diagnosis was assessed by computed tomography, endosonography and magnetic nuclear resonance (MNR). Medical treatment with octreotid during three weeks was effective but duodenal stenosis persisted. Finally, pylorus preserving pancreaticoduodenectomy was performed. Microscopy examination confirmed the diagnosis and the efficiency of medical treatment. A review of the literature about cystic dystrophy is done.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10352740

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  4 in total

Review 1.  Cystic dystrophy of the duodenal wall is not always associated with chronic pancreatitis.

Authors:  Raffaele Pezzilli; Donatella Santini; Lucia Calculli; Riccardo Casadei; Antonio Maria Morselli-Labate; Andrea Imbrogno; Dario Fabbri; Giovanni Taffurelli; Claudio Ricci; Roberto Corinaldesi
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

Review 2.  EUS mini probes in diagnosis of cystic dystrophy of duodenal wall in heterotopic pancreas: a case report.

Authors:  Ivan Jovanovic; Srbislav Knezevic; Marjan Micev; Miodrag Krstic
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

3.  Pancreas-preserving duodenal resections vs pancreatoduodenectomy for groove pancreatitis. Should we revisit treatment algorithm for groove pancreatitis?

Authors:  Vyacheslav Egorov; Roman Petrov; Aleksandr Schegolev; Elena Dubova; Andrey Vankovich; Eugeny Kondratyev; Andrey Dobriakov; Dmitry Kalinin; Natalia Schvetz; Elena Poputchikova
Journal:  World J Gastrointest Surg       Date:  2021-01-27

4.  Pancreas-preserving approach to "paraduodenal pancreatitis" treatment: why, when, and how? Experience of treatment of 62 patients with duodenal dystrophy.

Authors:  V I Egorov; A N Vankovich; R V Petrov; N S Starostina; A Ts Butkevich; A V Sazhin; E A Stepanova
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.